Novartis India Share PriceNovartis India

₹716.85
-1.35 (-0.19%)
As on 27 September, 2023 | 10:58 BSE: 500672 NSE: NOVARTINDISIN: INE234A01025

Novartis India Performance

Day Range

  • Low 714
  • High 720.4
716.85

52 Week Range

  • Low 537
  • High 909
716.85
  • Open Price720.2
  • Previous Close718.2
  • Volume2509

Start SIP in Novartis India

Start SIP

Novartis India Share Price

  • Over 1 Month -0.58%
  • Over 3 Month -11.39%
  • Over 6 Month 25.86%
  • Over 1 Year 5.6%

Novartis India Key Statistics

P/E Ratio 24.8
PEG Ratio 0.4
Market Cap Cr 1,770
Price to Book Ratio 2.3
EPS 40.8
Dividend 6.6
Relative Strength Index 38.47
Money Flow Index 59.55
MACD Signal -1.43
Average True Range 15.53

Novartis India Investment Rating

  • Master Rating:
  • Novartis India has an operating revenue of Rs. 348.42 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 30% is great, ROE of 13% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 32 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Novartis India Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 91768010212198
Operating Expenses Qtr Cr 736773858993
Operating Profit Qtr Cr 179816326
Depreciation Qtr Cr 221111
Interest Qtr Cr 000010
Tax Qtr Cr 8-2734-8
Net Profit Qtr Cr 202581852-23
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 437433
Operating Expenses Annual Cr 314373
Operating Profit Annual in Cr 6527
Depreciation Cr 610
Interest Annual Cr 25
Tax Annual Cr 120
Net Profit Annual Cr 103-4
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 4539
Cash from Investing Activity Annual Cr -15387
Cash from Financing Annual Activity Cr -30-36
Net Cash Flow Annual Cr -13990
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 776692
Fixed Assets Annual Cr 1924
Total Non Current Assets Annual Cr 306249
Total Current Assets Annual Cr 677709
Total Assets Annual Cr 983958
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 314280
ROE Annual % 13-1
ROCE Annual % 147
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3315
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Novartis India Technicals

EMA & SMA

Current Price
₹716.85
-1.35 (-0.19%)
  • Bullish Moving Average
  • ___
  • 3
  • Bearish Moving Average
  • ___
  • 13
  • 20 Day
  • ₹733.64
  • 50 Day
  • ₹740.16
  • 100 Day
  • ₹731.18
  • 200 Day
  • ₹709.77
  • 20 Day
  • ₹732.52
  • 50 Day
  • ₹744.39
  • 100 Day
  • ₹751.44
  • 200 Day
  • ₹686.26

Novartis India Resistance and Support

PIVOT
₹721.35
Resistance
First Resistance ₹725.7
Second Resistance ₹733.2
Third Resistance ₹737.55
RSI 38.47
MFI 59.55
MACD Single Line -1.43
MACD -2.5
Support
First Resistance ₹713.85
Second Resistance ₹709.5
Third Resistance ₹702

Novartis India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 12,835 772,410 60.18
Week 15,952 831,918 52.15
1 Month 19,539 966,192 49.45
6 Month 36,535 1,838,829 50.33

Novartis India Result Highlights

Novartis India Synopsis

NSE-Medical-Diversified

Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 378.74 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2023. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.
Market Cap 1,773
Sales 348
Shares in Float 0.72
No of funds 43
Yield 1.39
Book Value 2.29
U/D Vol ratio 1.1
LTDebt / Equity
Alpha 0.02
Beta 0.36

Novartis India

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 70.68%70.68%70.68%70.68%
Mutual Funds
Insurance Companies 0.74%0.76%0.76%0.76%
Foreign Portfolio Investors 0.23%0.17%0.17%0.17%
Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
Individual Investors 23.09%23.04%23.01%23.02%
Others 5.25%5.34%5.37%5.36%

Novartis India Management

Name Designation
Mr. Christopher Snook Chairman
Mr. Sanjay Murdeshwar Vice Chairman & Mng.Director
Ms. Shilpa Joshi WholeTime Director & CFO
Ms. Sandra Martryes Independent Director
Mr. Jai Hiremath Independent Director
Mr. Sanker Parameswaran Independent Director

Novartis India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Novartis India Corporate Action

Date Purpose Remarks
2023-07-26 Quarterly Results
2023-05-10 Audited Results, Final & Special Dividend
2023-02-08 Quarterly Results
2022-11-09 Quarterly Results
2022-07-27 Quarterly Results

Novartis India MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 8
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Novartis India FAQs

What is Share Price of Novartis India ?

Novartis India share price is ₹716 As on 27 September, 2023 | 10:44

What is the Market Cap of Novartis India ?

The Market Cap of Novartis India is ₹1770 Cr As on 27 September, 2023 | 10:44

What is the P/E ratio of Novartis India ?

The P/E ratio of Novartis India is 24.8 As on 27 September, 2023 | 10:44

What is the PB ratio of Novartis India ?

The PB ratio of Novartis India is 2.3 As on 27 September, 2023 | 10:44

Q2FY23